Pliant Therapeutics, Inc.
PLRX
$1.19
$0.043.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -25.54% | -22.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.18% | -38.22% | |||
| Operating Income | 25.18% | 38.22% | |||
| Income Before Tax | 10.36% | 39.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 10.36% | 39.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.36% | 39.26% | |||
| EBIT | 25.18% | 38.22% | |||
| EBITDA | 25.32% | 38.57% | |||
| EPS Basic | 10.41% | 39.28% | |||
| Normalized Basic EPS | 26.58% | 39.51% | |||
| EPS Diluted | 10.41% | 39.28% | |||
| Normalized Diluted EPS | 26.58% | 39.51% | |||
| Average Basic Shares Outstanding | 0.07% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.07% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||